4月29日，康辰药业获中银证券买入评级，近一个月康辰药业获得4份研报关注。
研报预计公司2023年实现营业收入9.20亿元，同比增加6.15%，归母净利润1.50亿元，同比增加48.24%。2024年第一季度公司营业收入1.99亿元，同比增加20.67%，归母净利润0.42亿元，同比增加62.28%。中银证券指出，公司主力产品“苏灵”市场份额增长，新药研发项目积极推进，预计这些因素将成为公司新的发展动力。
风险提示：市场竞争加剧风险、新药研发进度不及预期风险、医药行业政策风险。
English
Back
- Markets
- Features
- News
- Community
- Learn
- Help Center
- About
- Offers & Rewards
- Welcome RewardsOpen an account and get up to HKD1800!
- Enjoy limited-time 5%+5% returns on Cash PlusInvest any amount and enjoy a 5% average return on Cash Plus + 5% welcome reward
- Join Futubull Membership ProgramUnlock 11 Premier Benefits
- Referral PromotionBring a friend and collect up to HK$600 in rewards
- Learn PremiumAnalyst 1V1 online teaching
- Stock TransferSwitch to Futu and get up to HK$7,000 in rewards
- English
- 繁體中文
- 简体中文
- Dark
- Light
- Headlines
- 康辰药业获中银证券买入评级，利润端表现亮眼
康辰药业获中银证券买入评级，利润端表现亮眼
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Hot News
Updated
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.